research and development Archives -

Astellas Pharma chief medical officer Bernhardt Zeiher talks about the evolution of R&D in life sciences Research and

Inside the changing tides of life science research

https://pharmaphorum.com/r-d/inside-the-changing-tides-of-life-science-research/

Why VCs fell in love with pharma R&D in 2021

mike.hammerton@pharmaphorum.com COVID-19, Deep Dive, Deep Dive: Research and Development, Jonah Comstock, Megan Zweig, Nooman Haque, research and development, Rock Health 0 Comment

For many years, those inside the pharma industry have been telling the same old story about innovation: pharma

Why VCs fell in love with pharma R&D in 2021

https://pharmaphorum.com/r-d/why-vcs-fell-in-love-with-pharma-rd-in-2021/

Deep Dive/ R&D/ Views & Analysis

Seeing double: the rise of digital twins in life sciences

mike.hammerton@pharmaphorum.com COVID-19, Deep Dive, Deep Dive: Research and Development, Markus Gershater, research and development 0 Comment

Little more than a decade ago, the concept of digital twins in life science research may have sounded

Seeing double: the rise of digital twins in life sciences

https://pharmaphorum.com/r-d/seeing-double-the-rise-of-digital-twins-in-life-sciences/

Deep Dive/ R&D/ Views & Analysis

Does the answer to advancing rare disease treatment lie in real-world data?

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Research and Development, Emmanuelle Quiles, Janssen, Neil Davie, rare disease, research and development 0 Comment

What do 300 million people have in common? They are living with rare diseases that are defined by

Does the answer to advancing rare disease treatment lie in real-world data?

https://pharmaphorum.com/r-d/does-the-answer-to-advancing-rare-disease-treatment-lie-in-real-world-data/

Deep Dive/ R&D/ Views & Analysis

Medical Informatics in Rare Disease – the bridge between two worlds

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Research and Development, IQVIA, Joanne M Hackett, rare disease, research and development 0 Comment

Rare diseases bring with them a multitude of challenges for those affected, their relatives and care providers. Modern

Medical Informatics in Rare Disease – the bridge between two worlds

https://pharmaphorum.com/r-d/medical-informatics-in-rare-disease/

Deep Dive/ R&D/ Views & Analysis

Using cross-functional teams to develop a product’s value story

mike.hammerton@pharmaphorum.com Béranger Lueza, Deep Dive, Deep Dive: Research and Development, ICON, Jessica Cherian, research and development, Tanya Brinsden 0 Comment

Tanya Brinsden, senior VP of operations at ICON Global Medical Communications and Pubs Hub, Jessica Cherian, VP of

Using cross-functional teams to develop a product’s value story

https://pharmaphorum.com/r-d/using-cross-functional-teams-to-develop-a-products-value-story/

Deep Dive/ R&D/ Views & Analysis

Think global, act local: rethinking commercialisation models

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Research and Development, Eversana, Mike Ryan, research and development 0 Comment

The global market for life sciences is changing rapidly. Fuelled by technological advancements and a global pandemic, there

Think global, act local: rethinking commercialisation models

https://pharmaphorum.com/r-d/think-global-act-local-rethinking-commercialisation-models/

Deep Dive/ R&D/ Views & Analysis

Amplifying the voices in rare diseases

mike.hammerton@pharmaphorum.com Axon, Deep Dive, Deep Dive: Research and Development, Dr Emma Lemon, rare disease, research and development 0 Comment

There are approximately 300 million people around the world living with a rare disease. Yet, until relatively recently,

Amplifying the voices in rare diseases

https://pharmaphorum.com/r-d/amplifying-the-voices-in-rare-diseases/

A page from Rock Health's 2021 digital health funding report

News/ R&D

Digital health companies enabling R&D topped 2021 US investment, Rock Health says

Jonah Comstock AI drug development, digital health, research and development, Rock Health 0 Comment

According to Rock Health’s annual digital health funding report, US-based digital health companies enabling life sciences research and

Digital health companies enabling R&D topped 2021 US investment, Rock Health says

https://pharmaphorum.com/news-digital/digital-health-companies-enabling-rd-topped-2021-us-investment-rock-health-says/

Trending

research and development

Login